GreyBrook logotype
Investor Login Investor Login

醫療保健

投資策略

與我們的房地産投資策略不同,高博的醫療保健投資組合包括作爲委托人對商業化階段的醫療器械和醫療保健服務公司進行非常有選擇性的和重點的投資。我們利用專業知識來幫助尋找和評估獨特的商業機會並建立有效的管理團隊。我們顯示了在幫助企業釋放其真正增長潜力方面的良好業績記錄。 從 1990 年代早期,作爲激光視力矯正先驅到我們最近積極投資與我們共同致力于促進人類健康的公司,我們有選擇地利用自有資本投資,並充分利用我們管理團隊的深厚專業知識和在數十年期間在行業內獲得的夥伴關係。 我們是機會主義的醫療保健投資者,我們投資那些能够啓發我們的創意想法,同時可以通過與强大的管理團隊一起發揮戰略性和積極作用來對這些創意想法的結果産生積極的影響。

Investments in Focus

Greenbrook TMS(納斯達克股票代碼:GBNH,多倫多證券交易所股票代碼:GTMS)是經顱磁刺激 (TMS) 療法的領先提供商,這是一種經 FDA 批准的非侵入性療法,用于治療美國的重度抑鬱症和其他精神健康問題。

阅读更多

Delos is a global wellness pioneer that is working with organizations and industry leaders around the world to improve the health and wellness aspects of their buildings and indoor environments to positively impact the health outcomes of people in those environments.

阅读更多
Greybrook

Greenbrook TMS 通過 128 個由公司運營的治療中心進行業務運營,是美國經顱磁刺激 (TMS) 療法的領先提供商。 TMS 療法能够對已知與情緒調節直接相關的特定大腦區域提供局部電磁刺激。 Greenbrook已為超過 17,000 名患有抑鬱症的患者提供了超過 620,000 次 TMS 治療。 自 Greenbrook 2011 年成立以來,Greybrook 通過我們在醫療保健服務商業化方面的深厚專業知識,持續發揮支持公司管理和幫助釋放公司增長潜力的關鍵作用。

訪問網站
Greybrook

Greybrook invested in Delos, a New York based wellness real estate and technology company and partnered to establish its presence in Canada through the formation of Delos Canada. The firm’s mission is to help Canadian businesses, real estate owners, and the public sector advance human health and well-being through more thoughtful design and improvement of the buildings and interior spaces we inhabit every day. We play a critical role in supporting the Delos Canada team in working with the real estate development community, leading Canadian business and all levels of government to help implement Delos’ evidence-based productions and solutions in offices, schools, long-term care facilities, public venues, and new residential communities across Canada.

Read More

醫療保健領域的投資

Partner Greybrook
Partner Greybrook
Partner Greybrook
Partner Greybrook
Partner Greybrook